AIA
AIMZ Investment Advisors Portfolio holdings
AUM
$299M
This Quarter Return
-1.88%
1 Year Return
+12.69%
3 Year Return
+66.69%
5 Year Return
+124.55%
10 Year Return
+294.34%
AUM
$222M
AUM Growth
+$222M
(-0.65%)
Cap. Flow
+$3.57M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
33.52%
Holding
116
New
2
Increased
29
Reduced
43
Closed
3
Top Buys
| 1 |
AstraZeneca
AZN
|
$3.83M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$2.9M |
| 3 |
Incyte
INCY
|
$1.74M |
| 4 |
Bristol-Myers Squibb
BMY
|
$609K |
| 5 |
Vanguard Value ETF
VTV
|
$323K |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.42M |
| 2 |
Adobe
ADBE
|
$173K |
| 3 |
Huntington Bancshares
HBAN
|
$162K |
| 4 |
Microsoft
MSFT
|
$162K |
| 5 |
T Rowe Price
TROW
|
$149K |
Sector Composition
| 1 | Technology | 32.38% |
| 2 | Healthcare | 28.32% |
| 3 | Industrials | 11.46% |
| 4 | Financials | 8.63% |
| 5 | Consumer Discretionary | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$3.45T
| $14.5M | 6.56% |
102,672
-483
| -0.5% | -$68.3K |
|
|
2
Microsoft
MSFT
$3.77T
| $10.1M | 4.58% |
35,995
-573
| -2% | -$162K |
|
3
Infosys
INFY
$69.7B
| $7.41M | 3.34% |
332,895
-2,672
| -0.8% | -$59.5K |
|
4
Qualcomm
QCOM
$173B
| $7.03M | 3.17% |
54,463
-1,145
| -2% | -$148K |
|
|
5
T Rowe Price
TROW
$23.6B
| $6.98M | 3.15% |
35,488
-755
| -2% | -$149K |
|
6
Regeneron Pharmaceuticals
REGN
$61.5B
| $6.84M | 3.09% |
11,299
-140
| -1% | -$84.7K |
|
7
NetApp
NTAP
$22.6B
| $5.95M | 2.68% |
66,277
-1,447
| -2% | -$130K |
|
8
Meta Platforms (Facebook)
META
$1.86T
| $5.52M | 2.49% |
16,254
+134
| +0.8% | +$45.5K |
|
9
Expeditors International
EXPD
$16.4B
| $5.07M | 2.29% |
42,594
-230
| -0.5% | -$27.4K |
|
10
Gilead Sciences
GILD
$140B
| $4.8M | 2.17% |
68,769
+306
| +0.4% | +$21.4K |
|
|
11
Vertex Pharmaceuticals
VRTX
$100B
| $4.3M | 1.94% |
23,680
+16,005
| +209% | +$2.9M |
|
12
Cisco
CSCO
$274B
| $4.19M | 1.89% |
77,060
-1,033
| -1% | -$56.2K |
|
13
C.H. Robinson
CHRW
$15.2B
| $4.04M | 1.82% |
46,410
-317
| -0.7% | -$27.6K |
|
|
14
Adobe
ADBE
$151B
| $3.95M | 1.78% |
6,865
-300
| -4% | -$173K |
|
|
15
AstraZeneca
AZN
$248B
| $3.83M | 1.73% |
+63,808
| New | +$3.83M |
|
16
GSK
GSK
$79.9B
| $3.61M | 1.63% |
94,499
+1,709
| +2% | +$65.3K |
|
|
WBA
17
DELISTED
Walgreens Boots Alliance
WBA
| $3.54M | 1.6% |
75,321
-568
| -0.7% | -$26.7K |
|
18
Berkshire Hathaway Class B
BRK.B
$1.09T
| $3.27M | 1.47% |
11,964
-65
| -0.5% | -$17.7K |
|
19
Amgen
AMGN
$155B
| $3.18M | 1.44% |
14,953
-26
| -0.2% | -$5.53K |
|
20
Cintas
CTAS
$84.6B
| $3.12M | 1.41% |
8,187
-25
| -0.3% | -$9.52K |
|
21
Franklin Resources
BEN
$13.3B
| $3.11M | 1.4% |
104,712
-1,544
| -1% | -$45.9K |
|
|
22
Bristol-Myers Squibb
BMY
$96B
| $3.09M | 1.39% |
52,151
+10,288
| +25% | +$609K |
|
23
Emergent Biosolutions
EBS
$443M
| $3.06M | 1.38% |
61,050
+3,750
| +7% | +$188K |
|
24
Dolby
DLB
$6.87B
| $2.99M | 1.35% |
33,936
-458
| -1% | -$40.3K |
|
25
IBM
IBM
$227B
| $2.95M | 1.33% |
21,208
-491
| -2% | -$68.2K |
|